The TriVerse primary knee system is designed to offer similar surgical performance in both surgery centres and hospitals. Credit: Angelo Esslinger / Pixabay.

Exactech has obtained 510(k) clearance for its TriVerse primary knee replacement system from the US Food and Drug Administration (FDA).

The new primary knee system has been designed to provide cruciate retaining, anterior stabilised and posterior stabilised constructs.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

It is intended to offer similar surgical performance in both surgery centres and hospitals.

The TriVerse primary knee replacement system adds to Exactech’s knee solutions portfolio, which includes primary and revision implants and instruments as well as the company’s balanced knee system and completely integrated Guided Personalized Surgery (GPS) platform.

The company stated that the insert bearings for the TriVerse knee system will be available in highly crosslinked vitamin E-stabilised polyethylene only.

Exactech chief marketing officer and large joints senior vice-president Adam Hayden said: “The TriVerse primary knee system is positioned to be a powerful addition to Exactech’s portfolio that leverages proven design principles and data from hundreds of thousands of total knee replacement patients.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

“TriVerse will offer orthopaedic surgeons an impactful solution that is developed using proven implant design features, intraoperative flexibility and a straightforward approach.”

The company plans a limited-scale commercialisation of the TriVerse primary knee replacement system from the second quarter of next year.

The new knee replacement system will be available alongside a compact set of adjustable mechanical instrumentation.

It is also planned to be compatible with Exactech’s ExactechGPS system in future.

Exactech is engaged in developing and producing implants, instrumentation and smart technologies for joint replacement surgery.

In July, the company introduced the Equinoxe Shoulder Planning App v2.1 in the US.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact